Optical Coherence Tomography to guIde stent placeMent durIng percutaneouS coronary intErvention: a randomised controlled trial

niversity Hospitals Bristol NHS Foundation Trust0 个研究点目标入组 128 人开始时间: 2015年3月11日最近更新: 2019年7月1日

试验速览

暂无简介。

•A participant may enter study if ALL of the following apply:
•1. Adults of either sex aged 30 to 90 years who are undergoing EITHER,
•1.1. Elective PCI for the treatment of CAD OR
•1.2. Urgent PCI for the treatment of ACS
•2. Patients who are willing and able to give written informed consent for participation in the study
•3. Patients who are anticipated to have at least a 20 mm stent length in at least one lesion

•A participant may not enter study if ANY of the following apply:
•1. Patients unable to provide written informed consent.
•2. Patient undergoing emergency PCI
•3. Patients that have had previous PCI within the target vessel.
•4. Women who are pregnant or breast feeding
•5. Haemodynamic instability
•6. Renal impairment (eGFR =50 ml/min)
•7. Multivessel PCI (>2 vessels) during a single procedure
•8. Left main stem disease
•9. Estimated angiographic vessel calibre <2.5mm or >4.5mm
•10. Additional significant disease (>50% stenosis) in same vessel proximal or distal to culprit lesion
•11. Target vessels / lesions of excessive tortuosity
•12. Patients participating in another interventional study

发起方

niversity Hospitals Bristol NHS Foundation Trust